Literature DB >> 23051950

Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry.

Ravi V Shah1, DaJuanicia Holmes, Monique Anderson, Tracy Y Wang, Michael C Kontos, Stephen D Wiviott, Benjamin M Scirica.   

Abstract

BACKGROUND: Patients with acute myocardial infarction (MI) complicated by heart failure (HF) are subject to higher mortality during the index hospitalization. Early risk prediction and intervention may help prevent HF-related morbidity and mortality. METHODS AND
RESULTS: We examined 77 675 ST-elevation MI and 110 128 non-ST-elevation patients with MI without cardiogenic shock or HF at presentation treated at 609 hospitals in Acute Coronary Treatment and Intervention Outcomes Network Registry (ACTION) Registry-Get With The Guidelines between January 1, 2007, and March 31, 2011. Logistic regression identified patient characteristics associated with development of in-hospital HF. Overall, 3.8% of patients with MI developed in-hospital HF, which was associated with higher mortality in both ST-elevation MI and non-ST elevation MI. In multivariable logistic regression, left ventricular ejection fraction ≤30%, prior HF, diabetes mellitus, female sex, ST-elevation MI, and hypertension (all P<0.005) were independently associated with in-hospital HF. Patients who developed HF during non-ST-elevation MI were more likely to be medically managed without catheterization (30% versus 13% with HF, P<0.0001) or had longer delays to surgical or percutaneous revascularization. Patients with ST-elevation MI and HF were less likely to receive primary percutaneous coronary revascularization (84% versus 79% with HF, P<0.0001), and more likely to receive thrombolytic therapy (14% versus 11%; P=0.0001).
CONCLUSIONS: Patients with MI who develop HF during hospitalization have a higher risk clinical profile and greater mortality, but may be less likely to receive revascularization in a timely fashion. Targeting these highest risk patients may improve outcome post-MI.

Entities:  

Mesh:

Year:  2012        PMID: 23051950     DOI: 10.1161/CIRCHEARTFAILURE.112.968180

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  16 in total

1.  Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.

Authors:  Waqas T Qureshi; Zhu-Ming Zhang; Patricia P Chang; Wayne D Rosamond; Dalane W Kitzman; Lynne E Wagenknecht; Elsayed Z Soliman
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

2.  An epicardial delivery of nitroglycerine by active hydraulic ventricular support drug delivery system improves cardiac function in a rat model.

Authors:  Xue Li; Reyaj Mikrani; Cunyu Li; Muhammad Naveed; Ziwei Liu; Muhammad Abbas; Yijie Cheng; Lei Han; Zhijie Wang; Xiaohui Zhou
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

3.  A cardiac troponin I study in a minimally invasive myocardial infarction canine model.

Authors:  Reyaj Mikrani; Cuilan Liang; Muhammad Naveed; Asghar Ali Kamboh; Muhammad Abbas; Birendra Chaurasiya; Li Xue; Zhou Xiaohui
Journal:  J Appl Biomed       Date:  2018-11-23       Impact factor: 1.797

4.  The influence of heart failure on clinical and economic outcomes among older adults ≥75 years of age with acute myocardial infarction.

Authors:  Swetha Pasala; Lauren B Cooper; Mitchell A Psotka; Shashank S Sinha; Christopher R deFilippi; Henry Tran; Behnam Tehrani; Matthew Sherwood; Kelly Epps; Wayne Batchelor; Abdulla A Damluji
Journal:  Am Heart J       Date:  2021-12-16       Impact factor: 4.749

5.  Sex-related differences in plasma amino acids of patients with ST-elevation myocardial infarction and glycine as risk marker of acute heart failure with preserved ejection fraction.

Authors:  Oleg B Iaremenko; Nataliia Kh Iordanova; Petro F Dudka; Tamara M Kuchmerovska
Journal:  Amino Acids       Date:  2022-07-02       Impact factor: 3.789

Review 6.  Heart Failure After Right Ventricular Myocardial Infarction.

Authors:  Matthias P Nägele; Andreas J Flammer
Journal:  Curr Heart Fail Rep       Date:  2022-10-05

7.  Chronic Porphyromonas gingivalis lipopolysaccharide induces adverse myocardial infarction wound healing through activation of CD8+ T cells.

Authors:  Yusra Zaidi; Alexa Corker; Valeriia Y Vasileva; Kimberly Oviedo; Connor Graham; Kyrie Wilson; John Martino; Miguel Troncoso; Philip Broughton; Daria V Ilatovskaya; Merry L Lindsey; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-01       Impact factor: 5.125

8.  Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.

Authors:  Lucas Antonelli; Marcelo Katz; Fernando Bacal; Marcia Regina Pinho Makdisse; Alessandra Graça Correa; Carolina Pereira; Marcelo Franken; Anderson Nunes Fava; Carlos Vicente Serrano Junior; Antonio Eduardo Pereira Pesaro
Journal:  Arq Bras Cardiol       Date:  2015-05-29       Impact factor: 2.000

9.  In-hospital outcomes after primary percutaneous coronary intervention according to left ventricular ejection fraction.

Authors:  Hossein Vakili; Roxana Sadeghi; Parisa Rezapoor; Latif Gachkar
Journal:  ARYA Atheroscler       Date:  2014-07

10.  Porous nanofibrous poly(L-lactic acid) scaffolds supporting cardiovascular progenitor cells for cardiac tissue engineering.

Authors:  Qihai Liu; Shuo Tian; Chao Zhao; Xin Chen; Ienglam Lei; Zhong Wang; Peter X Ma
Journal:  Acta Biomater       Date:  2015-08-14       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.